article thumbnail

Episode 384: Antiracism in Medicine – Episode 26 – Racial and Gender Health Disparities in Youth Suicide: Part 1

The Clinical Problem Solvers

Dr. Benton mentors clinical and research physicians, fellows, and postdoctoral trainees. Clinically, he cares for youth and families through the Department of Psychiatry & Behavioral Sciences and the new Division of Addiction Medicine at Boston Children’s Hospital. Child and Adolescent Psychiatric Clinics of North America.

article thumbnail

Long Time Passing: Where Have All the De Novo Decision Summaries Gone?

FDA Law

The De Novo process provides a regulatory pathway to classify novel devices for which general controls alone or general and special controls provide reasonable assurance of safety and effectiveness for the intended use. Each of these De Novos can represent a clinical advance. De Novos now play an important role in product advancement.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Critics Suggest FDA Approving Aduhelm Will Erode the “Public Trust”: What About Patients’ Trust?

FDA Law

For 6 years, I served as a patient liaison within FDA in what was then called the Office of Special Health Issues. Over the years, this function expanded to cancer (renamed the Office of AIDS and Special Health Issues) and, ultimately, all serious and life-threatening diseases (dropping the AIDS nomenclature).

article thumbnail

Older adults with advanced chronic kidney disease and access to palliative care: Retrospective cohort study in primary care

Canadian Family Physician

Setting St Michael’s Hospital Academic Family Health Team, including 5 clinics and an interdisciplinary home-based outreach team, in Toronto, Ont. Results The study included 47 older adults with advanced CKD who were not undergoing dialysis and receiving primary care.

article thumbnail

Does the Drug Shortage White Paper Fall Short?

FDA Law

In its report, Drug Shortages: Root Causes and Potential Solutions, FDA explains that the equipment needed to produce sterile injectables is highly specialized and expensive, meaning that in a shortage situation, production capacity cannot be substantially increased without taking the time and expense of procuring and qualifying new equipment.

article thumbnail

Hastening Death by Stopping Eating and Drinking: Hope Wechkin, Thaddeus Pope, & Josh Briscoe

GeriPal

I was part of a writing group that wrote clinical guidelines for VSET for voluntarily stopping eating and drinking. And she was from Oregon, of course, and in Oregon in 2012, she had completed an advanced directive for stopping eating and drinking once she had advanced dementia. Why did you write this paper? So this is really.

IT 89
article thumbnail

Optimizing Nutrition in Aging: A Podcast with Anna Pleet, Elizabeth Eckstrom, and Emily Johnston

GeriPal

Now there’s evidence for some more specialized hormonal conditions. So I’m hearing, and I’d love to talk about specific diets and maybe the evidence for them, but before we do that, how should we ask about this in our clinics? Eric 18:14 Elizabeth, how do you bring it up in your clinic? Go on, Anna.

IT 118